Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xingxin Li

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Haematologica|June 23, 2022
Impaired immunosuppressive role of myeloid-derived suppressor cells in acquired aplastic anemiaPeiyuan Dong, Lingyun Chen, Hongfei Wu, et al.
Stem Cell Research & Therapy|February 15, 2020
Multifaceted characterization of the signatures and efficacy of mesenchymal stem/stromal cells in acquired aplastic anemiaJiali Huo, Leisheng Zhang, Xiang Ren, et al.
Blood Science (Baltimore, Md.)|April 11, 2022
The novel SLC40A1 (T419I) variant results in a loss-of-function phenotype and may provide insights into the mechanism of large granular lymphocytic leukemia and pure red cell aplasiaHongfei Wu, Xiang Ren, Meili Ge, et al.
Frontiers in Immunology|February 16, 2026
Low-dose cyclophosphamide combined with standard immunosuppressive therapy improves early response rates in severe aplastic anemiaHong Pan, Zhen Gao, Lele Zhang, et al.
The New England Journal of Medicine|January 14, 2026
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic AnemiaRuonan Li, Hong Pan, Lele Zhang, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Haematologica|June 23, 2022
Impaired immunosuppressive role of myeloid-derived suppressor cells in acquired aplastic anemiaPeiyuan Dong, Lingyun Chen, Hongfei Wu, et al.
Stem Cell Research & Therapy|February 15, 2020
Multifaceted characterization of the signatures and efficacy of mesenchymal stem/stromal cells in acquired aplastic anemiaJiali Huo, Leisheng Zhang, Xiang Ren, et al.
Blood Science (Baltimore, Md.)|April 11, 2022
The novel SLC40A1 (T419I) variant results in a loss-of-function phenotype and may provide insights into the mechanism of large granular lymphocytic leukemia and pure red cell aplasiaHongfei Wu, Xiang Ren, Meili Ge, et al.
Frontiers in Immunology|February 16, 2026
Low-dose cyclophosphamide combined with standard immunosuppressive therapy improves early response rates in severe aplastic anemiaHong Pan, Zhen Gao, Lele Zhang, et al.
The New England Journal of Medicine|January 14, 2026
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic AnemiaRuonan Li, Hong Pan, Lele Zhang, et al.
Pageof 6